Eps Diluted - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.2 PLN -0.18% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
EPS (Diluted) Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
EPS (Diluted)
-zł4
CAGR 3-Years
-22%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
EPS (Diluted)
zł0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-21%
M
Medicofarma Biotech SA
WSE:MDB
EPS (Diluted)
zł0
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
EPS (Diluted)
zł3
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's EPS (Diluted)?
EPS (Diluted)
-4.1 PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's EPS (Diluted) amounts to -4.1 PLN.

What is Ryvu Therapeutics SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-36%

Over the last year, the EPS (Diluted) growth was 11%. The average annual EPS (Diluted) growth rates for Ryvu Therapeutics SA have been -22% over the past three years , -36% over the past five years .

Back to Top